JP2003523331A - 官能基が付与されたβ−(1,3)−グルカン誘導体の調製方法 - Google Patents

官能基が付与されたβ−(1,3)−グルカン誘導体の調製方法

Info

Publication number
JP2003523331A
JP2003523331A JP2001557884A JP2001557884A JP2003523331A JP 2003523331 A JP2003523331 A JP 2003523331A JP 2001557884 A JP2001557884 A JP 2001557884A JP 2001557884 A JP2001557884 A JP 2001557884A JP 2003523331 A JP2003523331 A JP 2003523331A
Authority
JP
Japan
Prior art keywords
group
glycosyl
carbon atoms
formula
benzyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2001557884A
Other languages
English (en)
Japanese (ja)
Inventor
ジャン−クロード・イヴァン
フラン・ジャモワ
ヴァンサン・フェリエール
ダニエル・プルスクレック
Original Assignee
ラボラトワール ゴエマール
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ラボラトワール ゴエマール filed Critical ラボラトワール ゴエマール
Publication of JP2003523331A publication Critical patent/JP2003523331A/ja
Pending legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H5/00Compounds containing saccharide radicals in which the hetero bonds to oxygen have been replaced by the same number of hetero bonds to halogen, nitrogen, sulfur, selenium, or tellurium
    • C07H5/08Compounds containing saccharide radicals in which the hetero bonds to oxygen have been replaced by the same number of hetero bonds to halogen, nitrogen, sulfur, selenium, or tellurium to sulfur, selenium or tellurium
    • C07H5/10Compounds containing saccharide radicals in which the hetero bonds to oxygen have been replaced by the same number of hetero bonds to halogen, nitrogen, sulfur, selenium, or tellurium to sulfur, selenium or tellurium to sulfur
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H13/00Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids
    • C07H13/02Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids by carboxylic acids
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/02Acyclic radicals, not substituted by cyclic structures
    • C07H15/04Acyclic radicals, not substituted by cyclic structures attached to an oxygen atom of the saccharide radical

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Steroid Compounds (AREA)
  • Cosmetics (AREA)
JP2001557884A 2000-02-04 2001-02-02 官能基が付与されたβ−(1,3)−グルカン誘導体の調製方法 Pending JP2003523331A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR0001429A FR2804684B1 (fr) 2000-02-04 2000-02-04 Procede pour la preparation de derives fonctionnalises de beta-(1,3)-glucanes
FR00/01429 2000-02-04
PCT/FR2001/000329 WO2001057053A1 (fr) 2000-02-04 2001-02-02 PROCEDE POUR LA PREPARATION DE DERIVES FONCTIONNALISES DE β-(1,3)-GLUCANES

Publications (1)

Publication Number Publication Date
JP2003523331A true JP2003523331A (ja) 2003-08-05

Family

ID=8846670

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2001557884A Pending JP2003523331A (ja) 2000-02-04 2001-02-02 官能基が付与されたβ−(1,3)−グルカン誘導体の調製方法

Country Status (11)

Country Link
US (1) US6951934B2 (de)
EP (1) EP1252171B1 (de)
JP (1) JP2003523331A (de)
AT (1) ATE370155T1 (de)
AU (1) AU2001231973A1 (de)
CA (1) CA2399161C (de)
DE (1) DE60129929T2 (de)
ES (1) ES2292557T3 (de)
FR (1) FR2804684B1 (de)
PT (1) PT1252171E (de)
WO (1) WO2001057053A1 (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050065114A1 (en) * 2003-09-23 2005-03-24 Jean-Claude Yvin Therapeutical treatment with oligo-beta- (1,3) -glucans, drugs used in said treatment
US7070778B2 (en) 2003-10-30 2006-07-04 Laboratoire Goemar Sa Therapeutical combination against cancer
FR2910322B1 (fr) * 2006-12-22 2009-10-30 Mer Soc Par Actions Simplifiee Utilisation d'oligo-b-(1,3)-glucanes modifies pour le traite traitement de maladies du systeme immunitaire, oligo-b-(1,3) glucane-(1,3)-mannose, oligo-b-(1,3)-glucane-(1,3)-mannitol et leurs derives, ...
US20100076239A1 (en) * 2007-09-07 2010-03-25 University Of South Florida Asymmetric cyclopropanation of electron-deficient olefins with diazo reagents
EP2920193A4 (de) * 2012-11-16 2016-09-14 Univ Arizona State Synthese von tensiden auf der basis von kohlehydraten

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GR860379B (en) * 1985-02-22 1986-06-11 Akzo Nv Novel disaccharide and trisaccharide derivatives of the lipid a type
US5721368A (en) * 1996-07-22 1998-02-24 Merck & Co. Inc. Process for synthesizing carbapenem side chain intermediates
FR2777281B1 (fr) * 1998-04-14 2000-06-30 Goemar Lab Sa Procede de synthese du d-laminaribiose

Also Published As

Publication number Publication date
ATE370155T1 (de) 2007-09-15
DE60129929T2 (de) 2008-04-30
US6951934B2 (en) 2005-10-04
CA2399161A1 (en) 2001-08-09
PT1252171E (pt) 2007-11-15
FR2804684B1 (fr) 2002-06-28
FR2804684A1 (fr) 2001-08-10
US20030045706A1 (en) 2003-03-06
WO2001057053A1 (fr) 2001-08-09
DE60129929D1 (de) 2007-09-27
EP1252171A1 (de) 2002-10-30
AU2001231973A1 (en) 2001-08-14
CA2399161C (en) 2010-10-12
ES2292557T3 (es) 2008-03-16
EP1252171B1 (de) 2007-08-15

Similar Documents

Publication Publication Date Title
Lam et al. Solution-and solid-phase oligosaccharide synthesis using glucosyl iodides: a comparative study
EP2348028B1 (de) Verfahren zur chemischen Synthese von Lipochitooligosacchariden
US5319080A (en) Bicyclic nucleosides, oligonucleotides, process for their preparation and intermediates
EP2382226B1 (de) Verfahren zur synthese von l-fucosyl-di- oder oligosacchariden und neue 2,3,4-tribenzylfucosylderivate als zwischenprodukte dafür
ITMI20100524A1 (it) Processo per la sintesi di azacitidina e decitabina
JPWO1997038001A1 (ja) 1−(2−デオキシ−2−フルオロ−4−チオ−β−D−アラビノフラノシル)シトシン
FR2709754A1 (fr) Composés 2' ou 3'-déoxy- et 2', 3'-didéoxy-beta-L-pentofuranonucléosides, procédé de préparation et application thérapeutique, notamment anti-virale.
FR2751334A1 (fr) Polysaccharides synthetiques, procede pour leur preparation et compositions pharmaceutiques les contenant
EP2417145A1 (de) 6-sialyllactosesalze und verfahren zu deren synthese und zur synthese anderer a-sialyloligosaccharide
JP3231765B2 (ja) デメチルエピポドフィロトキシンの製造方法
JP7598148B2 (ja) オリゴ糖合成にかかる繰り返し二糖とそのオリゴマーの製造法
JP2003523331A (ja) 官能基が付与されたβ−(1,3)−グルカン誘導体の調製方法
WO2011040984A1 (en) Synthesis of decitabine
JP5550234B2 (ja) フラノース誘導体の製造方法
DE69019052T2 (de) Verfahren zur Herstellung von 2'Deoxy-5-trifluoromethyl-ss-uridin.
Ohnishi et al. Synthesis of a novel asparagine-linked heptasaccharide structure via p-methoxybenzyl-assisted β-mannosylation
WO2007099392A2 (en) Convergent synthesis of carbohydrate building blocks
JP2006516249A (ja) 2−デオキシ−d−グルコースの合成方法
WO2008087340A2 (fr) UTILISATION D' OLIGO-β-(1,3)-GLUCANES MODIFIES POUR LE TRAITEMENT DE MALADIES DU SYSTEME IMMUNITAIRE, OLIGO-β-(1,3)-GLUCANE-(1,3)- MANNOSE, OLIGO-β-(1.3)-GLUCANE-(1,3)- MANNITOL ET LEURS DERIVES, LEURS PROCEDES DE PREPARATION ET MEDICAMENTS LES CONTENANT
Kaluza et al. Potential Anti-HIV Active Pyranoid Analogs of AZT
JPH0689041B2 (ja) オリゴガラクチュロン酸の製造法
JPH07324094A (ja) 4−アセトアミド−4−デオキシ−d−アルトロピラノース及びその誘導体
JPH09241288A (ja) グリコシル化合物の立体選択的な製造方法
HK1152312B (en) Method of producing 2' -deoxy-5-azacytidine (decitabine)